<DOC>
	<DOC>NCT01152060</DOC>
	<brief_summary>Lamivudine treatment for HBV-DNA negative HBV-GN patients.</brief_summary>
	<brief_title>Treatment for HBV-MN Patients in Chinese: An Open Parallel Controlled Trial</brief_title>
	<detailed_description>lamivudine and predinisone treatment for HBV-DNA negative HBV-GN patients.</detailed_description>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Adult HBVGN patients with biopsyproven MN, heavy protinuria, HBsAg or HBeAg positive, HBVDNA negative Primary MN patients, HBVDNA positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>remission of proteinuria</keyword>
	<keyword>HBVe-antigen</keyword>
</DOC>